BNP Paribas Issuance (P14GK0) ニュース

Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints. And they had various other indications inc

Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 

Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.

A/S tells you where JarHead is headed….

Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin

.0005 next!

The Note is either/or you moron.

Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5

Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,

There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20

Foolish rabbit … tricks are for kids! :-D

It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA

Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.

I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,

Au contrar, it is the constant droning of the naysayers constantly moving the "they will never achieve " narrative. 

As in, the phase 3 will never complete recruitment, the phase 3 won't complete, the SAP will never be accepted, the peer reviewed paper will not be published, it won't

You demand SP2 answer, even-though-you're-a professional cricket farmer. You evade responding to facts, facts that legitimately counter your false story, and that counter your stupid SEC filings misreading. Countering facts that evidence hole after hole in your scam story?

The fraud

No.

Re: RVNC revisions

Mildly interesting that the terms of the debt financing are a First and Second Lien debt arranged by Ares for $467 and $375 million, with the First Lien paying interest of SOFR + 5.75% and the Second Lien paying 16%. And this is for the merged companies, Revance

OK, so I didn't need to give you a follow. I could just follow your posts as I was doing. No problem.

I'm very curious who were still buying this Soon-To-Be-$0.000001 Pos Scam after they saw Super Dangerous " DELINQUENT SEC Reporting " label/sign?

This label/sign means that for every $10,000 invested in GSTC at price levels $0.0003 or $0.0004 those positions will soon be worthy on

I don't remember attacking you...could you copy the "arrogance" post?

Rory had a serious propensity to exaggerate things.

Eventually people stopped believing his bullshit.

Sad really…

The Top 13 Index

Commentary: This index consists of all stocks picked 2 times or more. The index will be equal weighted. Without further ado here is the list.
[pre]
Symbol
1 $$
2 CCEL
3 ETCC
4 OPXS
5 VNDA
6 AES
7 BBAI